•  
  •  
  •  
  •  

2025-10-04 11:40:51

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • Pyramid Technoplast Ltd announces commencement of its Unit IX - Recycling plant
  • AstraZeneca Pharma India Ltd receives sale and distribution approval from CDSCO for Trastuzumab Deruxtecan 100mg/5mL vial lyophilized powder
  • Uni Abex Alloy Products Ltd to sell land at Thane for Rs. 244.23 crores
  • Kesar India Ltd purchases land at Nagpur
  • Uflex Ltd commissions enhanced capacity at Sanand

Keywords Selected:  ErisLifesciences

Stock Report

  • Eris Lifesciences receives ANVISA approval for Sterile Injectable Facility
  • Eris Lifesciences Receives ANVISA approval at its Ahmedabad campus
  • Eris Lifesciences designates Gopal Agrawal and Nita Borkar in leadership roles
  • Eris Lifesciences appoints Murari Ranganathan to spearhead Cardiometabolic Business
  • Eris Lifesciences Ltd Q1FY25 consolidated profit up QoQ at Rs. 83.18 crores
  • Eris Lifesciences acquires the commercial rights to Biocon Biologics' India Branded Formulations business
  • Eris Lifesciences Limited enters into term loan agreement with Citi Bank N.A.
  • Eris Lifesciences Ltd Q1 FY24 consolidated net profit higher at Rs. 94.85 crores
  • Eris Oaknet Healthcare Pvt Ltd transfers dermatalogy trademarks to Eris Lifesciences Ltd
  • Eris Lifesciences Ltd consolidated Q4FY23 PAT lower at Rs. 65.41 crores
  • Eris Lifesciences Ltd reports consolidated net profit of Rs. 101.85 crores in Q3 FY2023
  • Eris Lifesciences Ltd posts consolidated PAT of Rs. 120.30 crores in Q2FY23
  • Eris Lifesciences Ltd Board declares Interim Dividend of Rs. 7.35
  • Eris Lifesciences Ltd Q1FY2023 consolidated net profit up QoQ at Rs. 94.57 crores
  • Eris Lifesciences posts QoQ fall in consolidated PAT to Rs. 80.29 crores
  • Eris Lifesciences Q3FY22 consolidated net profit at Rs. 100.76 crores
  • Eris Lifesciences Ltd posts consolidated PAT of Rs. 118.39 crore in Q2FY22

Latest Post

  • Pyramid Technoplast Ltd announces commencement of its Unit IX - Recycling plant
  • AstraZeneca Pharma India Ltd receives sale and distribution approval from CDSCO for Trastuzumab Deruxtecan 100mg/5mL vial lyophilized powder
  • Uni Abex Alloy Products Ltd to sell land at Thane for Rs. 244.23 crores
  • Kesar India Ltd purchases land at Nagpur
  • Uflex Ltd commissions enhanced capacity at Sanand


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2024